Stimulation of renal gluconeogenesis by inhibition of the sodium pump.
D000090:Acetoacetates / Q000494:pharmacology; D000818:Animals; D001693:Biological Transport, Active; D002087:Butyrates / Q000494:pharmacology; D002245:Carbon Dioxide / Q000378:metabolism; D002247:Carbon Isotopes; D000242:Cyclic AMP / Q000494:pharmacology; D004357:Drug Synergism; D004837:Epinephrine / Q000494:pharmacology; D004976:Ethacrynic Acid / Q000494:pharmacology; D005665:Furosemide / Q000494:pharmacology; D005943:Gluconeogenesis / Q000187:drug effects*; D006019:Glycolysis / Q000187:drug effects; D007668:Kidney / Q000201:enzymology / Q000378:metabolism*; D007672:Kidney Cortex / Q000187:drug effects / Q000378:metabolism; D007684:Kidney Tubules / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D010042:Ouabain / Q000494:pharmacology; D011188:Potassium / Q000378:metabolism; D011773:Pyruvates / Q000378:metabolism; D051381:Rats; D012964:Sodium / Q000378:metabolism*
D000090:Acetoacetates; D002087:Butyrates; D002247:Carbon Isotopes; D011773:Pyruvates; D002245:Carbon Dioxide; D010042:Ouabain; D005665:Furosemide; D012964:Sodium; D000242:Cyclic AMP; D004976:Ethacrynic Acid; D011188:Potassium; D004837:Epinephrine